9310 A phase IIa study of tisotumab vedotin (HuMax (R)-TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer.
Authors
Vergote, IDean, Emma J
Lassen, U
De Bono, J
Drew, Y
Machiels, J
Nielsen, D
Arkenau, H
Forster, M
Jones, R
Slomovitz, B
Spicer, J
Johnson, M
Cornez, N
Gennigens, C
Fulton, B
Lisby, S
Basse, L
Coleman, R
Hong, D
Affiliation
Gynaecologie-verloskunde, University Hospital Leuven, 3000 - Leuven/BEIssue Date
2017